Clinical Trials on Atherosclerosis Risk in Argentina
Total 44 results
-
Santiago Gabriel MiriukaFundación para la Lucha contra las Enfermedades Neurológicas de la InfanciaCompletedAtherosclerosis | Atheroscleroses, Coronary | Atherosclerotic PlaqueArgentina
-
Austral University, ArgentinaRecruitingCardiovascular Diseases | Obesity | Diabetes | Atherosclerosis | Metabolic Syndrome | Cardiovascular Risk FactorArgentina
-
Institute for Clinical Effectiveness and Health...Inter-American Development BankUnknownModerate and High Cardiovascular RiskArgentina
-
Fundacion GESICAEscuela de Psicología Social Pichon Riviere; Corriente Salvador MazaActive, not recruitingCardiovascular Diseases | Cardiovascular Risk FactorArgentina
-
Codman & ShurtleffCompletedA Feasibility Study of the Cordis Neurovascular Self Expanding Stent System in Intracranial ArteriesAtherosclerosis | AneurysmArgentina
-
Eli Lilly and CompanyRecruitingElevated Lp(a) | Atherosclerotic Cardiovascular Disease (ASCVD)United States, Australia, Spain, Canada, Argentina, China, Italy, France, Japan, Taiwan, Korea, Republic of, Denmark, Germany, Hungary, Israel, Austria, Belgium, Netherlands, Brazil, Mexico, Romania, United Kingdom, Greece, Czechia, Poland and more
-
AmgenActive, not recruitingAtherosclerotic Cardiovascular DiseaseUnited States, Belgium, Spain, China, Korea, Republic of, Australia, Netherlands, Austria, Czechia, Taiwan, Italy, Portugal, Greece, Hong Kong, Hungary, United Kingdom, France, Bulgaria, Germany, Finland, Japan, Sweden, Canada, Denmark, Icelan... and more
-
Gustavo Zabert, MDAstraZenecaUnknownCOPD | Risk Factors | Diagnosis | Spirometry | Adult | Primary Care | Screening ScoreArgentina
-
AmgenCompletedAtherosclerotic Cardiovascular DiseaseCanada, United States, Belgium, Spain, China, Korea, Republic of, Australia, Netherlands, Austria, Czechia, Taiwan, Hungary, Italy, Portugal, United Kingdom, Greece, Hong Kong, Turkey, France, Bulgaria, Germany, Finland, Japan, Sweden, ... and more
-
Novartis PharmaceuticalsActive, not recruitingAtherosclerotic Cardiovascular DiseaseUnited States, China, South Africa, Spain, Austria, Belgium, Croatia, Estonia, Hungary, Taiwan, Turkey, Netherlands, Italy, Australia, Czechia, Denmark, France, Israel, Korea, Republic of, Thailand, Argentina, Bulgaria, Greece, Romania, Sloveni... and more
-
Novartis PharmaceuticalsRecruitingPrimary Prevention of Atherosclerotic Cardiovascular DiseaseUnited States, China, Italy, Spain, France, Netherlands, Poland, Switzerland, Taiwan, Greece, Thailand, Brazil, India, Hungary, Latvia, Mexico, Israel, Malaysia, Turkey, Argentina, Singapore, Australia, Belgium, Bulgaria, Denmark, Croatia, South... and more
-
MultiplAI Health LimitedFundación para la Lucha contra las Enfermedades Neurológicas de la InfanciaEnrolling by invitationCoronary Stenosis | Atherosclerotic Plaque | Aortic Calcification | Calcific Coronary Arteriosclerosis | Coronary PlaqueArgentina
-
Fundación para la Investigación del Hospital Clínico...Hospital General Universitario Gregorio Marañon; Germans Trias i Pujol Hospital and other collaboratorsCompletedModerated-high Risk of Postoperative Pulmonary Complication | Abdominal Surgery Expected More Than Two HoursSpain, United States, Argentina, Sweden
-
Centro de estudios en Cardiologia IntervencionistaRecruitingCoronary Artery Disease | Atherosclerosis | Acute Coronary Syndrome | Restenosis of Coronary Artery StentArgentina
-
BayerJanssen, LPCompletedAtherosclerosisGermany, Argentina, Brazil, Canada, Denmark, Israel, Korea, Republic of, Lebanon, Luxembourg, Mexico, Norway, Russian Federation, Slovenia, Sweden, Switzerland, Thailand, United Arab Emirates, United Kingdom
-
SanofiRegeneron PharmaceuticalsCompletedAtherosclerotic Cardiovascular DiseaseChina, Hong Kong, Austria, Bulgaria, Norway, Peru, France, Japan, Spain, Lithuania, Philippines, Israel, Belgium, Croatia, Poland, Hungary, Chile, Mexico, Latvia, Singapore, Switzerland, Colombia, Greece, Ukraine, Turkey, Finland, United States and more
-
SanofiCompletedCoronary AtherosclerosisKorea, Republic of, France, United States, Chile, Argentina, Australia, Brazil, Czech Republic, Russian Federation, Spain, Belgium, Canada, India, Mexico, Netherlands, Poland, Portugal, Turkey
-
AstraZenecaThe Cleveland ClinicCompletedCoronary AtherosclerosisUnited States, France, Italy, Mexico, Russian Federation, Poland, Netherlands, Canada, Argentina, Australia, Belgium, Hungary, Spain, Brazil
-
BioMarin PharmaceuticalCompletedIntermittent ClaudicationUnited States, Argentina
-
AstraZenecaCompletedAtherosclerosis | Hypercholesterolemia | Coronary Heart DiseaseChile, Argentina, Brazil, United States, Colombia, Lithuania, Netherlands, Peru, Venezuela
-
SanofiBristol-Myers SquibbCompletedAtrial Fibrillation | Vascular RiskUnited States, France, Canada, Brazil, Poland, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, Malaysia, Singapore, Taiwan, Belgium, Czech Republic, Mexico, Argentina, Denmark, Finland, Hungary, Norway, United... and more
-
Novartis PharmaceuticalsThe Cleveland ClinicCompletedCoronary Artery Disease (CAD) | Coronary AtherosclerosisItaly, Spain, Hungary, Australia, United States, Belgium, Canada, Germany, France, Argentina, Poland
-
BayerCompletedPeripheral Vascular DiseasesGermany, Switzerland, Argentina, Austria, Mexico, Brazil
-
Medtronic EndovascularCompletedPeripheral Arterial DiseaseKorea, Republic of, Belgium, Germany, Hungary, Singapore, Canada, Austria, United Kingdom, Australia, Argentina, Netherlands, Italy, Slovenia, Colombia, Czechia, Egypt, Finland, France, Greece, Israel, Lithuania, Poland, Portugal, Russian... and more
-
Novartis PharmaceuticalsCompletedLow and Int 1-risk Myelodysplastic SyndromeGermany, Canada, Korea, Republic of, Sweden, Spain, China, Argentina, Italy, United Kingdom, Algeria
-
Novo Nordisk A/SEnrolling by invitationHeart Failure | Chronic Kidney Disease | Cardiovascular RiskKorea, Republic of, China, United States, Argentina, Germany, Canada, Poland, Brazil
-
Novartis PharmaceuticalsRecruitingCoronary Artery DiseaseUnited States, Italy, Spain, France, Korea, Republic of, Hungary, Japan, Argentina, China, India, Belgium, Switzerland, United Kingdom, Canada, Australia, Brazil, Chile, Ireland
-
SanofiCompletedEfficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions (TAMARIS)Peripheral Vascular DiseasesFrance, Canada, Brazil, Poland, Russian Federation, Ukraine, Germany, Spain, Sweden, Switzerland, United States, Turkey, Singapore, Belgium, Czech Republic, Mexico, Japan, Austria, Denmark, Finland, Hungary, Italy, Korea, Republic of, Chil... and more
-
GlaxoSmithKlineCompletedAtherosclerosisUnited States, Russian Federation, Spain, Germany, Korea, Republic of, Sweden, Canada, Netherlands, Thailand, Hong Kong, Argentina, France, Mexico, Greece, Poland, Italy, India, Brazil, Latvia, Czech Republic
-
Novartis PharmaceuticalsCompletedAtherosclerosisChina, Germany, United States, Colombia, Romania, South Africa, Italy, Austria, Belgium, Croatia, Czechia, Estonia, Hungary, Japan, Russian Federation, Taiwan, Turkey, Netherlands, Australia, United Kingdom, Bulgaria, Greece, Slovenia, Norw... and more
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Heart and Stroke Foundation...RecruitingCardiovascular Diseases | Lung Diseases | Cancer | Risk Factor, Cardiovascular | Health Behavior | Injuries | Environmental Exposure | Renal Disease | Communicable DiseaseIndia, Saudi Arabia, Iran, Islamic Republic of, Peru, Pakistan, Argentina, Bangladesh, Brazil, Canada, Chile, China, Colombia, Kazakhstan, Kyrgyzstan, Malaysia, Palestinian Territory, occupied, Philippines, Poland, Russian Federation and more
-
ECRI bvUniversity of Bern; European Cardiovascular Research Center; Terumo Medical Corporation and other collaboratorsCompletedCoronary Artery Disease | PCI | High Bleeding RiskNetherlands, France, United Kingdom, Australia, Singapore, Japan, Italy, Poland, Spain, Switzerland, Israel, Argentina, Austria, Bahrain, Bangladesh, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, India, Korea, Republic... and more
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedCardiovascular Diseases | Diabetes Mellitus, Type 2 | Risk FactorsUnited States, Australia, Poland, Ukraine, United Kingdom, Belgium, Germany, France, Spain, Argentina, Colombia, Israel, Mexico, India, Canada, Netherlands, Sweden, Malaysia, New Zealand, Estonia, Russian Federation, Hungary, Norway, ... and more
-
Advaxis, Inc.Gynecologic Oncology GroupTerminatedHigh Risk Cervical Cancer | Advanced Cervical CancerUnited States, Argentina, Brazil, Canada, Chile, Korea, Republic of, Malaysia, Mexico, Poland, Russian Federation, Serbia, Spain, Taiwan, Ukraine
-
GlaxoSmithKlineCompletedAtherosclerosisUnited States, Argentina, Australia, France, Germany, Netherlands, Taiwan, Bulgaria, Estonia, Poland, Russian Federation, Spain, Belgium, Canada, Peru, Philippines, Sweden, Thailand, Korea, Republic of, Hong Kong, Hungary, Slovakia, Ukrain... and more
-
GlaxoSmithKlineCompletedAtherosclerosisUnited States, Germany, Estonia, Spain, Argentina, Canada, France, Netherlands, Australia, Bulgaria, Romania, Hungary, Denmark, India, New Zealand, Pakistan
-
Novo Nordisk A/SDuke Clinical Research InstituteNot yet recruitingCardiovascular Risk | Acute Myocardial Infarction (AMI)Canada, China, United States, Germany, Spain, Korea, Republic of, Netherlands, Australia, Italy, Denmark, India, United Kingdom, Argentina, Turkey, Mexico, Malaysia, Czechia, Poland, Brazil, France, Japan, Bulgaria, Greece, Israel
-
BayerJanssen Research & Development, LLC; Colorado Prevention CenterCompletedPeripheral Artery DiseasePoland, Belgium, France, Spain, China, Korea, Republic of, United States, Switzerland, Estonia, Portugal, Japan, Hungary, Canada, Netherlands, Finland, Austria, United Kingdom, Germany, Czechia, Thailand, Brazil, Denmark, Italy, Russian... and more
-
AstraZenecaCompletedPeripheral Artery DiseaseUnited States, Canada, France, Italy, Netherlands, Spain, United Kingdom, Czechia, Thailand, Russian Federation, Vietnam, Germany, Korea, Republic of, Brazil, Hungary, Mexico, Philippines, Turkey, China, Slovakia, Japan, Bulgaria, R... and more
-
BayerJanssen Research & Development, LLC; Population Health Research InstituteCompletedPrevention & ControlBelgium, Finland, France, China, United States, Colombia, Ireland, Philippines, Japan, Hungary, Canada, Germany, Australia, Chile, Czechia, Korea, Republic of, Malaysia, Brazil, Denmark, Israel, Russian Federation, South Africa, Ecu... and more
-
AstraZenecaCompletedSmoking | Hypertension | Obesity | Diabetes | Hyperlipidemia | Cardiovascular Risk FactorsSweden, France, Russian Federation, Spain, Turkey, United Kingdom, Germany, Norway, Austria, Belgium, Switzerland, Greece
-
AstraZenecaBristol-Myers Squibb; Hadassah Medical Organization; The TIMI Study GroupCompletedDiabetes Mellitus, Non-Insulin-Dependent | High Risk for Cardiovascular EventUnited States, Canada, France, Italy, Netherlands, Spain, Belgium, Thailand, Vietnam, Bulgaria, Korea, Republic of, Brazil, Philippines, Russian Federation, Turkey, Taiwan, Australia, Israel, South Africa, Germany, Japan, Czechia, H... and more
-
BayerRecruitingAcute Non-cardioembolic Ischemic Stroke | Prevention of Ischemic Stroke | High-risk Transient Ischemic AttackUnited States, Switzerland, Belgium, Sweden, Canada, Australia, Taiwan, Spain, Korea, Republic of, Latvia, Israel, Malaysia, Greece, Japan, Turkey, Netherlands, Romania, China, United Kingdom, Portugal, Italy, France, Slovakia, Austria, Czechi... and more
-
Novo Nordisk A/SRecruitingInflammation | Chronic Kidney Disease | Cardiovascular RiskKorea, Republic of, Spain, China, Taiwan, Mexico, Netherlands, Latvia, Malaysia, United States, Thailand, Italy, Hungary, Australia, Poland, South Africa, India, Portugal, Romania, United Kingdom, Brazil, Sweden, Lithuania, Japan, Serbia and more